Reinhart Partners’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176M Sell
928,660
-729,085
-44% -$108M 4.02% 3
2026
Q1
$154M Buy
1,657,745
+67,847
+4% +$6.01M 4.44% 1
2025
Q4
$128M Sell
1,589,898
-20,434
-1% -$1.71M 3.83% 5
2025
Q3
$157M Buy
1,610,332
+91,788
+6% +$7.39M 5.11% 1
2025
Q2
$106M Buy
1,518,544
+77,522
+5% +$4.42M 3.61% 7
2025
Q1
$71.6M Buy
1,441,022
+404,910
+39% +$25.6M 2.61% 16
2024
Q4
$72.4M Buy
1,036,112
+348,504
+51% +$28.9M 2.79% 13
2024
Q3
$72.1M Buy
687,608
+268,560
+64% +$31.4M 2.74% 10
2024
Q2
$59.6M Buy
419,048
+79,456
+23% +$9.16M 2.48% 13
2024
Q1
$37.9M Buy
+339,592
New +$40.5M 1.54% 26

Other funds holding ACLS

Reinhart Partners's ACLS Position: Q2 2026 in Review

Reinhart Partners reduced its Axcelis (ACLS) stake by 44% in Q2 2026, selling an estimated $108M and leaving 928,660 shares worth $176M. The position accounts for 4.02% of the portfolio, ranked #3.

Reinhart Partners first reported a position in ACLS in Q1 2024 and has held it in 10 quarters since. 40 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Reinhart Partners held 928,660 shares of Axcelis worth $176M as of Q2 2026.
  • Reinhart Partners sold 729,085 Axcelis shares in Q2 2026, an estimated $108M.
  • Axcelis made up 4.02% of Reinhart Partners's portfolio in Q2 2026, its #3 holding.
  • Reinhart Partners first reported a position in Axcelis in Q1 2024 and has held it in 10 quarters since.
  • 40 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Reinhart Partners's 13F filing for Q2 2026, filed 8 Jul 2026.